Payment overview · 2025
General Payments
$48.62
2 reported records · 2 companies
Healthcare provider profile · identity verified
Joseph Michael Dimaria
Allopathic & Osteopathic Physicians|Family Medicine · UTICA, NY · NPI 1952506230
Verified facts
What the public records show
CMS Open Payments records show Joseph Michael Dimaria received $48.62 in general payments during 2025 across 2 reported records.
Neurocrine BioSciences, Inc. accounted for 61.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ingrezza.
Neurocrine BioSciences, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported INGREZZA as an associated drug or biological on 126456 records involving 27390 distinct recipient NPIs. Public Medicare Part D data also shows 23 claims for Ingrezza by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $30.04 | 61.8% | 1 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $18.58 | 38.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $48.62 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $30.04 | 1 | 2025 |
Source payment records
|
|||||
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $18.58 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| INGREZZA ingrezza |
2025 | Ingrezza | 2024 | 23 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Neurocrine BioSciences, Inc. Exact reporting entity; no affiliate inference |
2025 | INGREZZA open payments reported associated product |
CMS Open Payments — General Payments 126456 supporting records · 27390 recipient NPIs · example record 1242766729 |
Ingrezza · 2024 Exact normalized brand match · 1 Part D row |
23 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Eliquis | Apixaban | 732 | 117 |
| Atorvastatin Calcium | Atorvastatin Calcium | 500 | 157 |
| Levothyroxine Sodium | Levothyroxine Sodium | 482 | 126 |
| Gabapentin | Gabapentin | 395 | 123 |
| Sertraline Hcl | Sertraline Hcl | 385 | 90 |
| Furosemide | Furosemide | 370 | 130 |
| Amlodipine Besylate | Amlodipine Besylate | 333 | 88 |
| Metoprolol Succinate | Metoprolol Succinate | 323 | 106 |
| Pantoprazole Sodium | Pantoprazole Sodium | 308 | 106 |
| Famotidine | Famotidine | 277 | 76 |
| Buspirone Hcl | Buspirone Hcl | 253 | 64 |
| Tamsulosin Hcl | Tamsulosin Hcl | 247 | 89 |
| Lisinopril | Lisinopril | 246 | 78 |
| Potassium Chloride | Potassium Chloride | 218 | 51 |
| Trazodone Hcl | Trazodone Hcl | 218 | 73 |
| Divalproex Sodium | Divalproex Sodium | 174 | 52 |
| Metoprolol Tartrate | Metoprolol Tartrate | 172 | 56 |
| Mirtazapine | Mirtazapine | 169 | 53 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 163 | 39 |
| Metformin Hcl | Metformin Hcl | 152 | 52 |
| Carvedilol | Carvedilol | 142 | 39 |
| Jardiance | Empagliflozin | 142 | 29 |
| Escitalopram Oxalate | Escitalopram Oxalate | 135 | 38 |
| Omeprazole | Omeprazole | 133 | 56 |
| Duloxetine Hcl | Duloxetine Hcl | 132 | 36 |
| Lorazepam | Lorazepam | 131 | 47 |
| Lactulose | Lactulose | 130 | 23 |
| Losartan Potassium | Losartan Potassium | 123 | 47 |
| Oxycodone Hcl | Oxycodone Hcl | 123 | 44 |
| Baclofen | Baclofen | 115 | 33 |
| Tramadol Hcl | Tramadol Hcl | 113 | 48 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 110 | 47 |
| Januvia | Sitagliptin Phosphate | 110 | 16 |
| Prednisone | Prednisone | 109 | 51 |
| Donepezil Hcl | Donepezil Hcl | 108 | 33 |
| Finasteride | Finasteride | 108 | 36 |
| Quetiapine Fumarate | Quetiapine Fumarate | 106 | 35 |
| Clopidogrel | Clopidogrel Bisulfate | 105 | 36 |
| Diclofenac Sodium | Diclofenac Sodium | 97 | 24 |
| Spironolactone | Spironolactone | 97 | 35 |
| Hydrochlorothiazide | Hydrochlorothiazide | 95 | 32 |
| Citalopram Hbr | Citalopram Hydrobromide | 94 | 30 |
| Xtampza Er | Oxycodone Myristate | 91 | suppressed |
| Latanoprost | Latanoprost | 88 | 27 |
| Levetiracetam | Levetiracetam | 87 | 18 |
| Torsemide | Torsemide | 85 | 30 |
| Xarelto | Rivaroxaban | 85 | 18 |
| Simvastatin | Simvastatin | 82 | 23 |
| Myrbetriq | Mirabegron | 78 | 16 |
| Allopurinol | Allopurinol | 77 | 26 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 76 | 33 |
| Bumetanide | Bumetanide | 72 | 20 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 71 | 52 |
| Ropinirole Hcl | Ropinirole Hcl | 71 | 16 |
| Memantine Hcl | Memantine Hcl | 70 | 20 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 69 | 32 |
| Metformin Hcl Er | Metformin Hcl | 67 | 23 |
| Ondansetron Hcl | Ondansetron Hcl | 65 | 45 |
| Entresto | Sacubitril/Valsartan | 63 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 62 | 35 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 61 | 18 |
| Rexulti | Brexpiprazole | 61 | suppressed |
| Pregabalin | Pregabalin | 60 | 20 |
| Clonazepam | Clonazepam | 59 | 19 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 58 | 57 |
| Albuterol Sulfate | Albuterol Sulfate | 58 | 16 |
| Fluoxetine Hcl | Fluoxetine Hcl | 58 | 16 |
| Olanzapine | Olanzapine | 58 | 21 |
| Midodrine Hcl | Midodrine Hcl | 55 | 25 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 54 | 24 |
| Trulicity | Dulaglutide | 53 | 13 |
| Topiramate | Topiramate | 51 | 12 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 50 | 17 |
| Hydralazine Hcl | Hydralazine Hcl | 50 | 17 |
| Scopolamine | Scopolamine | 50 | 15 |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 49 | suppressed |
| Atenolol | Atenolol | 48 | 14 |
| Meclizine Hcl | Meclizine Hcl | 48 | 15 |
| Montelukast Sodium | Montelukast Sodium | 48 | 20 |
| Santyl | Collagenase Clostridium Hist. | 48 | 28 |
| Enoxaparin Sodium | Enoxaparin Sodium | 45 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 45 | 19 |
| Pravastatin Sodium | Pravastatin Sodium | 44 | 15 |
| Brimonidine Tartrate | Brimonidine Tartrate | 43 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 43 | 11 |
| Digoxin | Digoxin | 42 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 42 | 18 |
| Nyamyc | Nystatin | 42 | 19 |
| Propranolol Hcl | Propranolol Hcl | 42 | 11 |
| Alendronate Sodium | Alendronate Sodium | 41 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 40 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 39 | 15 |
| Haloperidol | Haloperidol | 39 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 39 | 35 |
| Sucralfate | Sucralfate | 38 | 16 |
| Tizanidine Hcl | Tizanidine Hcl | 38 | 14 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 37 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 37 | 24 |
| Benztropine Mesylate | Benztropine Mesylate | 36 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 36 | 14 |
| Nifedipine Er | Nifedipine | 35 | 11 |
| Xifaxan | Rifaximin | 35 | suppressed |
| Budesonide | Budesonide | 34 | 13 |
| Timolol Maleate | Timolol Maleate | 33 | suppressed |
| Glimepiride | Glimepiride | 32 | 11 |
| Risperidone | Risperidone | 32 | suppressed |
| Valsartan | Valsartan | 32 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 31 | 13 |
| Cephalexin | Cephalexin | 31 | 27 |
| Diltiazem Hcl | Diltiazem Hcl | 31 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 31 | 21 |
| Morphine Sulfate Er | Morphine Sulfate | 31 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 30 | suppressed |
| Novolog Flexpen | Insulin Aspart | 30 | 15 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 29 | 21 |
| Bupropion Hcl Sr | Bupropion Hcl | 28 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 28 | 11 |
| Lamotrigine | Lamotrigine | 28 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 28 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 27 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 27 | suppressed |
| Nystatin | Nystatin | 27 | 18 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 26 | 18 |
| Memantine Hcl Er | Memantine Hcl | 26 | suppressed |
| Methimazole | Methimazole | 26 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 26 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 25 | suppressed |
| Ibuprofen | Ibuprofen | 25 | 19 |
| Meloxicam | Meloxicam | 25 | 11 |
| Lidocaine Hcl | Lidocaine Hcl | 24 | 20 |
| Azithromycin | Azithromycin | 23 | 12 |
| Doxycycline Hyclate | Doxycycline Hyclate | 23 | 19 |
| Fenofibrate | Fenofibrate | 23 | suppressed |
| Ingrezza | Valbenazine Tosylate | 23 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 23 | suppressed |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 23 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 23 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 23 | suppressed |
| Aripiprazole | Aripiprazole | 22 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 22 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 22 | suppressed |
| Oxycontin | Oxycodone Hcl | 22 | suppressed |
| Roflumilast | Roflumilast | 22 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 21 | suppressed |
| Ozempic | Semaglutide | 21 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 21 | suppressed |
| Clozapine | Clozapine | 20 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 20 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 20 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 19 | 15 |
| Glipizide | Glipizide | 19 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 18 | 11 |
| Celecoxib | Celecoxib | 18 | 13 |
| Megestrol Acetate | Megestrol Acetate | 18 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 18 | suppressed |
| Naproxen | Naproxen | 18 | 12 |
| Acetylcysteine | Acetylcysteine | 17 | suppressed |
| Brilinta | Ticagrelor | 17 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 17 | suppressed |
| Colchicine | Colchicine | 17 | suppressed |
| Diazepam | Diazepam | 17 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 17 | suppressed |
| Gemtesa | Vibegron | 17 | suppressed |
| Lacosamide | Lacosamide | 17 | suppressed |
| Metolazone | Metolazone | 17 | suppressed |
| Ranolazine Er | Ranolazine | 17 | suppressed |
| Austedo Xr | Deutetrabenazine | 16 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 16 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 16 | suppressed |
| Ezetimibe | Ezetimibe | 16 | suppressed |
| Lagevrio (Eua) | Molnupiravir | 16 | 15 |
| Linzess | Linaclotide | 16 | suppressed |
| Loperamide | Loperamide Hcl | 16 | 13 |
| Ondansetron Odt | Ondansetron | 16 | 13 |
| Pioglitazone Hcl | Pioglitazone Hcl | 16 | suppressed |
| Sulfasalazine | Sulfasalazine | 16 | suppressed |
| Amantadine | Amantadine Hcl | 15 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 15 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 15 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 15 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 15 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 15 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 14 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 14 | suppressed |
| Cimetidine | Cimetidine | 14 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 14 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 14 | suppressed |
| Fluphenazine Decanoate | Fluphenazine Decanoate | 14 | suppressed |
| Novolog Mix 70-30 | Insulin Aspart Prot/Insuln Asp | 14 | suppressed |
| Nystop | Nystatin | 14 | 12 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 14 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 13 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 13 | suppressed |
| Dovato | Dolutegravir Sodium/Lamivudine | 13 | suppressed |
| Humalog | Insulin Lispro | 13 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 13 | suppressed |
| Levofloxacin | Levofloxacin | 13 | 12 |
| Lithium Carbonate Er | Lithium Carbonate | 13 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 13 | suppressed |
| Rasagiline Mesylate | Rasagiline Mesylate | 13 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 12 | suppressed |
| Dilantin | Phenytoin Sodium Extended | 12 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 12 | suppressed |
| Ketoconazole | Ketoconazole | 12 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 11 | suppressed |
| Bupropion Xl | Bupropion Hcl | 11 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 11 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 11 | suppressed |
| Haloperidol Lactate | Haloperidol Lactate | 11 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 11 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 11 | suppressed |
| Lovastatin | Lovastatin | 11 | suppressed |
| Novolin R Flexpen | Insulin Regular, Human | 11 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 11 | suppressed |
| Primidone | Primidone | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $48.62 · 2 records | Neurocrine BioSciences, Inc. | FREESTYLE LIBRE 3, INGREZZA | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ingrezza play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Neurocrine BioSciences, Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error